Dr. Vanhove currently serves as the chief medical officer of Surrozen. Dr. Vanhove previously served as vice president of medical affairs and, subsequently, R&D search and evaluation at Jazz Pharmaceuticals since 2012. Prior to Jazz Pharmaceuticals, she was vice president, medical affairs at Depomed, Vice President clinical development at NeurogesX and a medical director and project team leader at XOMA. She began her career as a medical director at Abbott Laboratories in 1996. Dr. Vanhove earned an MD and a PhD in pharmacology from the Catholic University in Leuven, Belgium. She completed a fellowship in clinical pharmacology at Stanford University and received an MBA from St. Mary’s College in California. Dr. Vanhove has authored, or co-authored, several dozens of peer-reviewed articles, and is an inventor on several patents.